极低剂量下舌胺用于边界性人格障碍和耐治疗抑郁症
Mitchell Liester1, Rachel Wilkenson2, Barry Patterson3
1Department of Psychiatry, University of Colorado School of Medicine, Aurora, USA.
Cureus
|May 6, 2024
概括
非常低剂量的舌下胺在治疗边缘性人格障碍 (BPD) 和耐治疗抑郁症 (TRD) 中表现有前途. 这份病例报告表明,对于这些具有挑战性的精神疾病,这种药物具有潜在的疗效.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 边界性人格障碍 (BPD) 和耐治疗抑郁症 (TRD) 是普遍存在且难以治疗的心理健康状况.
- 胺,一种N-甲基-D-酸盐受体对抗剂,通过静脉注射表现出快速抗抑郁作用.
- 以前的研究表明,胺对BPD症状有潜在的益处,包括静脉和鼻腔内胺的病例报告.
研究的目的:
- 报告一个患有并发性BPD和TRD且症状有所改善的患者病例.
- 为了研究非常低剂量的舌下胺在治疗这些复杂的精神疾病中的潜在疗效.
主要方法:
- 一份病例报告详细介绍了一名被诊断患有BPD和TRD的女性的治疗方法.
- 非常低剂量的舌下胺的使用.
主要成果:
- 患有BPD和TRD的患者对非常低剂量的舌下胺治疗产生了积极反应.
- 在患者干预后观察到症状改善.
结论:
- 非常低剂量的舌下胺可能是BPD患者的可行和有效的治疗选择.
- 这种方法也可能对患有并发性TRD的个人有益.
- 需要进一步的研究来探索胺在精神疾病中的治疗潜力.
关键词:
一个AMPA受体的受体.边界性人格障碍 (bpd) 是一种人格障碍.大脑衍生的神经营养因子谷氨酸的调节障碍 谷氨酸的调节障碍低剂量的胺基因.增强神经可塑性 增强神经可塑性治疗耐药性抑郁症 (trd)更多相关视频
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.3K
09:55Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
Published on: March 8, 2018
12.4K
相关概念视频
01:25Borderline Personality Disorder
40
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
Genetic and Environmental Contributions
Borderline Personality...
40
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:26Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
01:23Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
01:14CNS Depressants: Barbiturates and Benzodiazepines
250
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
250
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170